
### [MONDO:0018545](http://purl.obolibrary.org/obo/MONDO_0018545)
**Label:** primary immunodeficiency with predisposition to severe viral infection

**Subclasses:** [MONDO:0014313](http://purl.obolibrary.org/obo/MONDO_0014313) (autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity), [MONDO:0014715](http://purl.obolibrary.org/obo/MONDO_0014715) (primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection), [MONDO:0014727](http://purl.obolibrary.org/obo/MONDO_0014727) (immunodeficiency 45; IMD45), 

**Mapped go classes:** [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0042119](http://purl.obolibrary.org/obo/GO_0042119) (neutrophil activation), [GO:0009897](http://purl.obolibrary.org/obo/GO_0009897) (external side of plasma membrane), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0019221](http://purl.obolibrary.org/obo/GO_0019221) (cytokine-mediated signaling pathway), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0019863](http://purl.obolibrary.org/obo/GO_0019863) (IgE binding), [GO:0019962](http://purl.obolibrary.org/obo/GO_0019962) (type I interferon binding), [GO:0035455](http://purl.obolibrary.org/obo/GO_0035455) (response to interferon-alpha), [GO:0019864](http://purl.obolibrary.org/obo/GO_0019864) (IgG binding), [GO:0035456](http://purl.obolibrary.org/obo/GO_0035456) (response to interferon-beta), [GO:0019767](http://purl.obolibrary.org/obo/GO_0019767) (IgE receptor activity), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0090140](http://purl.obolibrary.org/obo/GO_0090140) (regulation of mitochondrial fission), [GO:0044389](http://purl.obolibrary.org/obo/GO_0044389) (ubiquitin-like protein ligase binding), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0004896](http://purl.obolibrary.org/obo/GO_0004896) (cytokine receptor activity), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0060337](http://purl.obolibrary.org/obo/GO_0060337) (type I interferon signaling pathway), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0071222](http://purl.obolibrary.org/obo/GO_0071222) (cellular response to lipopolysaccharide), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0001932](http://purl.obolibrary.org/obo/GO_0001932) (regulation of protein phosphorylation), [GO:0045780](http://purl.obolibrary.org/obo/GO_0045780) (positive regulation of bone resorption), [GO:0019770](http://purl.obolibrary.org/obo/GO_0019770) (IgG receptor activity), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0004905](http://purl.obolibrary.org/obo/GO_0004905) (type I interferon receptor activity), [GO:0051930](http://purl.obolibrary.org/obo/GO_0051930) (regulation of sensory perception of pain), 

**Class expressions from DL-Learner:**

- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 55.00%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 55.00%
- Thing 52.02%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 40.36%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 40.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 40.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 40.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 40.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 40.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 40.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 40.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 40.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 40.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001041](http://purl.obolibrary.org/obo/GO_2001041) (null)) 40.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2000976](http://purl.obolibrary.org/obo/GO_2000976) (obsolete regulation of transcription from RNA polymerase II promoter involved in detection of glucose)) 40.36%


